Shasun Pharma has tanked nearly 9% to Rs 89, after the company reported 67% fall in its net profit to Rs 8.2 crore for the quarter ended December 2012. The company had posted a profit of Rs 24.6 crore during the previous corresponding quarter.
The consolidated net sales of the pharma company fell 13% to Rs 257.1 crore from Rs 295.8 crore on a year-on-year (y-o-y) basis.
The stock opened at Rs 95 on the Bombay Stock Exchange (BSE) and touched the intra-day low of Rs 86 in trades thus far. As many as 4,49,000 shares have changed hands, as compared to its two-week average of 3,12,000 shares.
The consolidated net sales of the pharma company fell 13% to Rs 257.1 crore from Rs 295.8 crore on a year-on-year (y-o-y) basis.
The stock opened at Rs 95 on the Bombay Stock Exchange (BSE) and touched the intra-day low of Rs 86 in trades thus far. As many as 4,49,000 shares have changed hands, as compared to its two-week average of 3,12,000 shares.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%